Skip to main content
Fig. 13 | European Journal of Medical Research

Fig. 13

From: Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinoma

Fig. 13

Role of TMEM79 on immune checkpoints and drug sensitivity. A, B Correlation of TMEM79 with immune checkpoints. C Correlation of expression of TMEM79 with CTLA4-negative and PD1-negative efficacy. D Correlation of expression of TMEM79 with CTLA4-negative and PD1-positive efficacy. E Correlation of expression of TMEM79 with CTLA4-positive and PD1-negative efficacy. F Correlation of expression of TMEM79 with CTLA4-positive and PD1-positive efficacy

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us